Detection of SARS-CoV-2 omicron variants by immunochromatographic kit.

Autor:	Oshiro S; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan., Mizukoshi F; Tochigi Prefectural Institute of Public Health and Environmental Science, Utsunomiya, Tochigi, Japan., Mizutani N; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan., Akiwa M; Microbiology Research Division, Kohjin Bio Co., Ltd., Saitama, Japan., Sekiguchi JI; Microbiology Research Division, Kohjin Bio Co., Ltd., Saitama, Japan., Tada T; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan., Yamamoto Y; Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan., Tabe Y; Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan., Miida T; Department of Clinical Laboratory Medicine, Juntendo University School of Medicine, Tokyo, Japan., Kirikae T; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan.
Jazyk:	angličtina
Zdroj:	Heliyon [Heliyon] 2023 Oct 12; Vol. 9 (10), pp. e20913. Date of Electronic Publication: 2023 Oct 12 (Print Publication: 2023).
DOI:	10.1016/j.heliyon.2023.e20913
Abstrakt:	An immunochromatographic kit using antibodies against recombinant N protein of an omicron B.1.1.529 of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was developed to detect SARS-CoV-2 omicron variants. The kit detected omicron variants (BA.1.18, BA.1.1, BA.2, BA.2.12.1, BA.2.75, BA.4.1, BA.4.6, BE.1, BA.5.2.1, XE, BF.7, BF.7.4.1, XBB.1, XBB.1.5 and BQ.1.1) as well as Wuhan strain and a delta variant. Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: MA and JS are employees of Kohjin Bio Co., Ltd. (© 2023 The Authors. Published by Elsevier Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu